Shanxi Zhanfa Biotechnology Co., Ltd. (Xi’an Zhanfa Health Technology, an affiliate of Baihong Group) specializes in regenerative medicine-based scalp care and franchise chain business. Its core competitive advantages lie in the EM3+1 microsphere cyst secretion technology and strong scientific research credentials, including the National First Prize for Progress in Science and Technology. This article conducts an in-depth analysis of the competitive landscape from four dimensions: direct rivals, technical competitors, regional peers and cross-industry disruptors.